AFT PHARMACEUTICALS LIMITED (AFP)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
AFP - AFT PHARMACEUTICALS LIMITED
FNArena Sector :
Pharmaceuticals & Biotech/Lifesciences
Year End: March
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Index:
FNArena Sector : Pharmaceuticals & Biotech/Lifesciences
Year End: March
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$4.15
15 Sep |
OPEN $4.15 |
HIGH $4.15 |
1,402 LOW $4.15 |
0.180| OTHER COMPANIES IN THE SAME SECTOR | |||
| CUV . ACR . AHZ . CSL . IDT . IVX . MSB . MYX . RNO . OSL . TFC . TIS . KZA . AGH . FTT . PAR . ADO . PYC . RAC . RCE . ZNO . AVH . LGP . SPL . ARX . 1AD . TLX . PNV . MVP . BNO . NXS . GSS . EOF . NEU . PAL . PBP . BOT . IMU . MDC . IMM . PXS . OPT . ANP . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
| Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | 6.9 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 105.6 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 32.2 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -2.3 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 6.88 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Return on Assets | xxx | xxx | xxx | xxx | xxx | 8.03 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | 28.86 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 13.96 % |
| Capex | xxx | xxx | xxx | xxx | xxx | 5.8 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 5.51 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -2.5 M |
Return on Assets
Return on Equity
Return on Total Capital
Capex
Capex % of Sales
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
0.0
No. Of Recommendations
0
AFP STOCK CHART
FNArena News on AFP
Latest Pharmaceuticals & Biotech/Lifesciences News
| 1 |
Beating The Biotech BluesSep 14 2021 - International |
| 2 |
Uncertainty Prevails For CSLAug 19 2021 - Australia |
| 3 |
Flying High – Medicinal Marijuana In AustraliaJul 26 2021 - Australia |
| 4 |
Wesfarmers On Drugs?Jul 13 2021 - Australia |
| 5 |
Is CSL’s Plasma Recovery Now Priced In?Jun 23 2021 - Australia |
| 6 |
CSL: Buy The DipJun 22 2021 - Technicals |
| 7 |
CSL To Retest Its High?May 25 2021 - Technicals |
| 8 |
Treasure Chest: CSL Plasma At Turning Point?May 05 2021 - Treasure Chest |
| 9 |
The War For DrugsApr 07 2021 - Weekly Reports |
| 10 |
Rudi’s View: CSL, The AnswersApr 01 2021 - Rudi's View |